Baxter International Inc., a global innovator in renal care, today announced U.S. Food and Drug Administration (FDA) clearance of its next-generation Artificial Kidney 98 (AK 98) dialysis machine, which is designed to be a portable and easy-to-use system to administer hemodialysis (HD) treatments. AK 98 offers encrypted, two-way connectivity, which enables the system to pull prescriptions directly from the electronic medical record (EMR) for simplified workflow and data handling. &l

The United States Food and Drug Administration (FDA) newly approved chlorine dioxide gas for contract sterilization of medical devices.  This breakthrough advancement for the medical industry was awarded to ClorDiSys Solutions, Inc, headquartered in Branchburg, NJ (registration number 3013115071).  This news follows public safety hazards of the industry standard, ethylene oxide.  ClorDiSys utilizes chlorine dioxide gas, a non-carcinogenic, United States Environmental Protection

NeuroSigma, Inc., a Los Angeles-based bioelectronics company that is commercializing trigeminal nerve stimulation (TNS) technology to treat neurological and neuropsychiatric disorders, announced today that the following patents have issued or received notices of allowance in Canada and Japan: Canadian patent no. 2776694 entitled Devices, Systems, and Methods for Treatment of Neuropsychiatric Disorders; issued November 17, 2020 Canadian patent no. 2821981 entitled

Hollister Incorporated, an independent, employee-owned company that develops, manufactures, and markets healthcare products worldwide has launched the Infyna Chic™ intermittent catheter, the latest in the company's line of hydrophilic catheter products, to the US market. Designed to help provide women who use catheters with a high level of discretion, the Infyna Chic catheter joins the existing US product portfolio, including the VaPro™ and Onli™ intermittent catheter br

Subtle Medical, a healthcare technology company revolutionizing the radiology industry by improving the quality and efficiency of medical imaging, announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the second generation of their SubtleMR™ image enhancement technology. The vendor-neutral software is a virtual upgrade to existing MRI machines that can boost scanner performance across the entire fleet. SubtleMR™ is an image processing soft

Samsara Vision, a company focused on bringing vision and freedom back to late-stage, age-related macular degeneration (AMD) patients through advanced visual prosthetic devices, announced it will partner with Medevise Consulting, a European-based commercial and clinically focused ophthalmology company, to build a dedicated commercial organization to support Samsara Vision’s Tsert SI Implantable Miniature Telescope (IMT) (by Isaac Lipshitz). The two companies will collaborate to advance c

Longeviti Neuro Solutions, a medtech company developing innovative solutions for complex brain surgery, today announced the launch of the Longeviti ClearFit Cover. The first-of-its-kind sonolucent ClearFit Cover is used to replace excised cranial bone following a neurosurgical procedure, enabling neurosurgeons to use ultrasound imaging to view neuroanatomy after brain surgery, and allowing long-term monitoring of their patients’ condition. Patients with hydrocephalus and other

The UK Healthcare Pavilion – the first virtual platform showcasing the very best of UK healthcare and Life Sciences – has partnered with The Middle East Medical Portal (MEMP) to both raise awareness and export UK innovation into the Middle East. MEMP is a UK & Dubai based company that serves both UK companies with market entry services and healthcare providers and authorities in the Middle East with world class importing of innovation. MEMP has exceptional market acc

Abbott announced the U.S. launch of NeuroSphere™ Virtual Clinic, a first-of-its-kind technology that allows patients to communicate with physicians, ensure proper settings and functionality, and receive new treatment settings remotely as needed. Approved by the U.S. Food and Drug Administration, the NeuroSphere Virtual Clinic has the potential to increase access to optimal treatment for patients suffering from chronic pain or movement disorders who don't live close to a care provide

Mainstay Medical Holdings plc announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain. “Launching ReActiv8, our Restorative Neurostimulation therapy, commercially in Australia is a significant milestone for our global commercial expansion. Several top Australian physicians have been part of our clinical studies since inception and are among the most experienced globally in selecting and treating pati